Metformin reduces intracellular reactive oxygen species levels by upregulating expression of the antioxidant thioredoxin via the AMPK-FOXO3 pathway
- PMID: 20398632
- DOI: 10.1016/j.bbrc.2010.04.017
Metformin reduces intracellular reactive oxygen species levels by upregulating expression of the antioxidant thioredoxin via the AMPK-FOXO3 pathway
Abstract
Background: Oxidative stress induced by free fatty acids plays a critical role in the pathogenesis of endothelial dysfunction and atherosclerosis in patients with metabolic syndrome. Reducing oxidative stress in these patients may prevent cardiovascular complications. The antidiabetic agent metformin has been reported to directly protect the cardiovascular system. In this study, we examined the effect of metformin on the intracellular levels of reactive oxygen species (ROS) induced by palmitic acid (PA) in human aortic endothelial cells and studied the molecular mechanisms involved.
Methods and results: We observed that metformin significantly reduced intracellular ROS levels induced by PA. Additionally, metformin increased the expression of the antioxidant thioredoxin (Trx), which mediated metformin's effects on ROS reduction. Metformin increased Trx expression through the AMP-activated protein kinase (AMPK) pathway. Metformin-regulated Trx at the transcriptional level and forkhead transcription factor 3 (FOXO3) was involved in this process.
Conclusion: These results suggest that metformin reduces ROS levels by inducing Trx expression through activation of the AMPK-FOXO3 pathway.
Copyright (c) 2010 Elsevier Inc. All rights reserved.
Similar articles
-
Activation of the AMPK-FOXO3 pathway reduces fatty acid-induced increase in intracellular reactive oxygen species by upregulating thioredoxin.Diabetes. 2009 Oct;58(10):2246-57. doi: 10.2337/db08-1512. Epub 2009 Jul 10. Diabetes. 2009. PMID: 19592618 Free PMC article.
-
Metformin reduces lipid accumulation in macrophages by inhibiting FOXO1-mediated transcription of fatty acid-binding protein 4.Biochem Biophys Res Commun. 2010 Feb 26;393(1):89-94. doi: 10.1016/j.bbrc.2010.01.086. Epub 2010 Jan 25. Biochem Biophys Res Commun. 2010. PMID: 20102700
-
Up-regulation of thioredoxin interacting protein (Txnip) by p38 MAPK and FOXO1 contributes to the impaired thioredoxin activity and increased ROS in glucose-treated endothelial cells.Biochem Biophys Res Commun. 2009 Apr 17;381(4):660-5. doi: 10.1016/j.bbrc.2009.02.132. Epub 2009 Feb 28. Biochem Biophys Res Commun. 2009. PMID: 19254690 Free PMC article.
-
Thioredoxin and protein kinases in redox signaling.Semin Cancer Biol. 2006 Dec;16(6):427-35. doi: 10.1016/j.semcancer.2006.09.003. Epub 2006 Sep 26. Semin Cancer Biol. 2006. PMID: 17081769 Review.
-
The Competence of 7,8-Diacetoxy-4-Methylcoumarin and Other Polyphenolic Acetates in Mitigating the Oxidative Stress and their Role in Angiogenesis.Curr Top Med Chem. 2015;15(2):179-86. Curr Top Med Chem. 2015. PMID: 25547104 Review.
Cited by
-
Mitigating diabetes associated with reactive oxygen species (ROS) and protein aggregation through pharmacological interventions.RSC Adv. 2024 May 29;14(25):17448-17460. doi: 10.1039/d4ra02349h. eCollection 2024 May 28. RSC Adv. 2024. PMID: 38813124 Free PMC article. Review.
-
Examining the clinical relevance of metformin as an antioxidant intervention.Front Pharmacol. 2024 Feb 1;15:1330797. doi: 10.3389/fphar.2024.1330797. eCollection 2024. Front Pharmacol. 2024. PMID: 38362157 Free PMC article.
-
Dose-response association of metformin use and risk of age-related macular degeneration among patients with type 2 diabetes mellitus: a population-based study.Front Pharmacol. 2023 Nov 22;14:1275095. doi: 10.3389/fphar.2023.1275095. eCollection 2023. Front Pharmacol. 2023. PMID: 38074151 Free PMC article.
-
Effects of metformin on parasitological, pathological changes in the brain and liver and immunological aspects during visceral toxocariasis in mice.Parasitol Res. 2023 Dec;122(12):3213-3231. doi: 10.1007/s00436-023-08011-1. Epub 2023 Oct 24. Parasitol Res. 2023. PMID: 37874393 Free PMC article.
-
GC-MS and GC-MS/MS measurement of malondialdehyde (MDA) in clinical studies: Pre-analytical and clinical considerations.J Mass Spectrom Adv Clin Lab. 2023 Aug 5;30:10-24. doi: 10.1016/j.jmsacl.2023.08.001. eCollection 2023 Nov. J Mass Spectrom Adv Clin Lab. 2023. PMID: 37637438 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
